U.S. bioplastics firm Danimer agrees $890 million deal to go public
Send a link to a friend
[October 05, 2020] By
Joshua Franklin
NEW YORK (Reuters) - Danimer Scientific
said on Monday it has agreed to go public by merging with blank-check
acquisition company with Live Oak Acquisition Corp <LOAK.N> in a deal
which values the U.S. bioplastics company at around $890 million.
It is the latest example of a company opting to go public by merging
with a so-called special purpose acquisition company (SPAC), rather than
through a traditional initial public offering (IPO).
A SPAC is a shell company which raises cash in an initial public
offering (IPO) with the goal of buying an unidentified private company,
usually within two years, in a deal which would then take the acquired
company public.
For Bainbridge, Georgia-based Danimer, the SPAC deal offered a quicker
route to the public markets and the funding the company needed than a
traditional IPO, Chief Executive Stephen Croskrey said in an interview.
"The SPAC route gives us the speed that we need to get to that capital.
We just don't have time to start a traditional IPO process right now,"
Croskrey said in an interview.

Reuters reported the agreement of the deal earlier on Monday.
Danimer sells renewable and sustainable biopolymers which are
biodegradable and compostable, a greener alternative to traditional
plastic products.
The global biopolymer market is seen exceeding $13 billion by 2021,
according to data from Transparency Market Research.
[to top of second column] |

A skier looks at a "plastic free zone" sign at the cable car
entrance of Pejo 3000, the first ski resort in Italy to ban
single-use plastic, in Peio, Trentino, Italy, January 30, 2020.
REUTERS/Yara Nardi

Danimer is in the process of scaling up production capacity of its biodegradable
plastics based on polyhydroxyalkanoate (PHA).
The deal with Live Oak will leave Danimer with an anticipated $385 million in
cash to continue its plans to expand capacity which were stunted earlier this
year by the COVID-19 pandemic.
"We plan to use the proceeds to build out the plant in Kentucky and to build a
greenfield facility," said Croskrey, who will continue as CEO after the deal.
Danimer has been "marginally profitable" for the last several years and expects
earnings to be break-even or slightly positive, Croskrey said.
Live Oak raised $200 million in May 2020 through an IPO on the New York Stock
Exchange. Upon completion of the deal, Danimer's stock will be publicly traded
on the NYSE.
In addition to the funds put into the deal by Live Oak's SPAC, a group of
investors including Federated Hermes Kaufmann Small Cap Fund and Apollo
Management <APO.N> have agreed to a private investment of $210 million.
(Reporting by Joshua Franklin in New York; Editing by Lisa Shumaker)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |